BioSpace

AI drug hunter Enveda raises $311M for late-stage obesity, inflammatory disease push

Tech darling Enveda has raised a total of $845 million in the past six years. The latest funding round is intended to pave the way for an IPO someday.

By BioSpace

1 min read

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights